TMAO: a potential mediator of clopidogrel resistance
Abstract Trimethylamine-N-oxide (TMAO) can activate platelets and increase thrombosis risk in clinical and experimental models. Meanwhile, the patients with coronary artery disease have higher serum TMAO level. However, it remains unknown whether Clopidogrel Resistance (CR) could be attributed to TM...
Saved in:
Main Authors: | Ruisong Ma, Wenwen Fu, Jing Zhang, Xiaorong Hu, Jun Yang, Hong Jiang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b6f0fcb212214607899980f1b51ec8cd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Untargeted metabolomics and transcriptomics identified glutathione metabolism disturbance and PCS and TMAO as potential biomarkers for ER stress in lung
by: Zijing Wang, et al.
Published: (2021) -
Resveratrol Attenuates Trimethylamine-<italic toggle="yes">N</italic>-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota
by: Ming-liang Chen, et al.
Published: (2016) -
Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO)
by: A. Gessner, et al.
Published: (2018) -
Gut microbiota derived trimethylamine N-oxide (TMAO) detection through molecularly imprinted polymer based sensor
by: G. B. V. S. Lakshmi, et al.
Published: (2021) -
Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
by: Gwang-Un Kim, et al.
Published: (2021)